In Vitro Anti-Microbial Activity and Anti-Cancer Potential of Novel Synthesized Carbamothioyl-Furan-2-Carboxamide Derivatives
作者:Muhammad Salman Javed、Muhammad Zubair、Komal Rizwan、Muhammad Jamil
DOI:10.3390/molecules28124583
日期:——
carbamothioyl-furan-2-carboxamide derivatives were synthesized using a one-pot strategy. Compounds were obtained in moderate to excellent yields (56–85%). Synthesized derivatives were evaluated for their anti-cancer (HepG2, Huh-7, and MCF-7 human cancer cell lines) and anti-microbial potential. Compound p-tolylcarbamothioyl)furan-2-carboxamide showed the highest anti-cancer activity at a concentration of
采用一锅法合成了一系列硫甲酰基-呋喃-2-甲酰胺衍生物。化合物的产率中等至优异 (56-85%)。评估了合成衍生物的抗癌(HepG2、Huh-7 和 MCF-7 人类癌细胞系)和抗微生物潜力。化合物对甲苯基氨基甲硫酰基)呋喃-2-甲酰胺在20 μg/mL浓度下对肝细胞癌的抗癌活性最高,细胞存活率为33.29%。所有化合物均对 HepG2、Huh-7 和 MCF-7 表现出显着的抗癌活性,而含有吲唑和 2,4-二硝基苯基的甲酰胺衍生物对所有测试的细胞系的效力均较弱。结果与标准药物阿霉素进行比较。甲酰胺衍生物具有 2, 4-二硝基苯基对所有细菌和真菌菌株均表现出显着抑制作用,抑制区 (IZ) 在 9-17 范围内,MIC 为 150.7-295 μg/mL。所有甲酰胺衍生物对所有测试的真菌菌株均表现出显着的抗真菌活性。使用庆大霉素作为标准药物。结果表明,硫甲酰基-呋喃-2-甲酰胺衍生物可能是抗癌和抗微生物药物的潜在来源。